Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3775826
Max Phase: Preclinical
Molecular Formula: C86H137N21O23S2
Molecular Weight: 1897.30
Molecule Type: Protein
Associated Items:
ID: ALA3775826
Max Phase: Preclinical
Molecular Formula: C86H137N21O23S2
Molecular Weight: 1897.30
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N2
Standard InChI: InChI=1S/C86H137N21O23S2/c1-11-46(8)68-82(126)94-52(22-15-17-33-88)73(117)101-67(45(6)7)85(129)106-35-19-24-60(106)80(124)97-55(38-65(113)114)71(115)90-40-64(112)100-66(44(4)5)81(125)95-53(30-31-62(89)110)74(118)102-69(47(9)12-2)83(127)99-58-43-132-131-42-57(78(122)103-68)92-63(111)39-91-79(123)59-23-18-34-105(59)84(128)61-25-20-36-107(61)86(130)70(48(10)13-3)104-76(120)56(41-108)98-72(116)51(21-14-16-32-87)93-75(119)54(96-77(58)121)37-49-26-28-50(109)29-27-49/h26-29,44-48,51-61,66-70,108-109H,11-25,30-43,87-88H2,1-10H3,(H2,89,110)(H,90,115)(H,91,123)(H,92,111)(H,93,119)(H,94,126)(H,95,125)(H,96,121)(H,97,124)(H,98,116)(H,99,127)(H,100,112)(H,101,117)(H,102,118)(H,103,122)(H,104,120)(H,113,114)/t46-,47-,48-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,66-,67-,68-,69-,70-/m0/s1
Standard InChI Key: UNVAWFQZJFSZMQ-PXSMJZSCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1897.30 | Molecular Weight (Monoisotopic): 1895.9638 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wang CK, Northfield SE, Huang YH, Ramos MC, Craik DJ.. (2016) Inhibition of tau aggregation using a naturally-occurring cyclic peptide scaffold., 109 [PMID:26807864] [10.1016/j.ejmech.2016.01.006] |
Source(1):